354 related articles for article (PubMed ID: 35422466)
1. The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments.
Almulla AF; Vasupanrajit A; Tunvirachaisakul C; Al-Hakeim HK; Solmi M; Verkerk R; Maes M
Mol Psychiatry; 2022 Sep; 27(9):3679-3691. PubMed ID: 35422466
[TBL] [Abstract][Full Text] [Related]
2. The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis.
Almulla AF; Supasitthumrong T; Tunvirachaisakul C; Algon AAA; Al-Hakeim HK; Maes M
BMC Infect Dis; 2022 Jul; 22(1):615. PubMed ID: 35840908
[TBL] [Abstract][Full Text] [Related]
3. The tryptophan catabolite or kynurenine pathway in autism spectrum disorder; a systematic review and meta-analysis.
Almulla AF; Thipakorn Y; Tunvirachaisakul C; Maes M
Autism Res; 2023 Dec; 16(12):2302-2315. PubMed ID: 37909397
[TBL] [Abstract][Full Text] [Related]
4. The Tryptophan Catabolite or Kynurenine Pathway in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
Almulla AF; Supasitthumrong T; Amrapala A; Tunvirachaisakul C; Jaleel AKA; Oxenkrug G; Al-Hakeim HK; Maes M
J Alzheimers Dis; 2022; 88(4):1325-1339. PubMed ID: 35786655
[TBL] [Abstract][Full Text] [Related]
5. The Tryptophan Catabolite or Kynurenine Pathway in a Major Depressive Episode with Melancholia, Psychotic Features and Suicidal Behaviors: A Systematic Review and Meta-Analysis.
Almulla AF; Thipakorn Y; Vasupanrajit A; Tunvirachaisakul C; Oxenkrug G; Al-Hakeim HK; Maes M
Cells; 2022 Oct; 11(19):. PubMed ID: 36231075
[TBL] [Abstract][Full Text] [Related]
6. The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis.
Almulla AF; Thipakorn Y; Vasupanrajit A; Abo Algon AA; Tunvirachaisakul C; Hashim Aljanabi AA; Oxenkrug G; Al-Hakeim HK; Maes M
Brain Behav Immun Health; 2022 Dec; 26():100537. PubMed ID: 36339964
[TBL] [Abstract][Full Text] [Related]
7. Deficit Schizophrenia Is Characterized by Defects in IgM-Mediated Responses to Tryptophan Catabolites (TRYCATs): a Paradigm Shift Towards Defects in Natural Self-Regulatory Immune Responses Coupled with Mucosa-Derived TRYCAT Pathway Activation.
Kanchanatawan B; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Anderson G; Maes M
Mol Neurobiol; 2018 Mar; 55(3):2214-2226. PubMed ID: 28290151
[TBL] [Abstract][Full Text] [Related]
8. Exercise and the Kynurenine pathway: Current state of knowledge and results from a randomized cross-over study comparing acute effects of endurance and resistance training.
Joisten N; Kummerhoff F; Koliamitra C; Schenk A; Walzik D; Hardt L; Knoop A; Thevis M; Kiesl D; Metcalfe AJ; Bloch W; Zimmer P
Exerc Immunol Rev; 2020; 26():24-42. PubMed ID: 32139353
[TBL] [Abstract][Full Text] [Related]
9. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
[TBL] [Abstract][Full Text] [Related]
10. Altered kynurenine pathway metabolism and association with disease activity in patients with systemic lupus.
Eryavuz Onmaz D; Tezcan D; Yilmaz S; Onmaz M; Unlu A
Amino Acids; 2023 Dec; 55(12):1937-1947. PubMed ID: 37925676
[TBL] [Abstract][Full Text] [Related]
11. Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid.
Kanchanatawan B; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Ormstad H; Anderson G; Maes M
Mol Neurobiol; 2018 Feb; 55(2):1524-1536. PubMed ID: 28181189
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the kynurenine pathway in human glioma pathophysiology.
Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ
PLoS One; 2014; 9(11):e112945. PubMed ID: 25415278
[TBL] [Abstract][Full Text] [Related]
13. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of kynurenine pathway and potential dynamic changes of kynurenine in schizophrenia: A systematic review and meta-analysis.
Cao B; Chen Y; Ren Z; Pan Z; McIntyre RS; Wang D
Neurosci Biobehav Rev; 2021 Apr; 123():203-214. PubMed ID: 33513412
[TBL] [Abstract][Full Text] [Related]
15. DSS-induced colitis activates the kynurenine pathway in serum and brain by affecting IDO-1 and gut microbiota.
Zhao LP; Wu J; Quan W; Zhou Y; Hong H; Niu GY; Li T; Huang SB; Qiao CM; Zhao WJ; Cui C; Shen YQ
Front Immunol; 2022; 13():1089200. PubMed ID: 36776388
[TBL] [Abstract][Full Text] [Related]
16. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.
Wichers MC; Koek GH; Robaeys G; Verkerk R; Scharpé S; Maes M
Mol Psychiatry; 2005 Jun; 10(6):538-44. PubMed ID: 15494706
[TBL] [Abstract][Full Text] [Related]
17. Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder.
Birner A; Platzer M; Bengesser SA; Dalkner N; Fellendorf FT; Queissner R; Pilz R; Rauch P; Maget A; Hamm C; Herzog-Eberhard S; Mangge H; Fuchs D; Moll N; Zelzer S; Schütze G; Schwarz M; Reininghaus B; Kapfhammer HP; Reininghaus EZ
PLoS One; 2017; 12(2):e0172699. PubMed ID: 28241062
[TBL] [Abstract][Full Text] [Related]
18. Depressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs.
Kanchanatawan B; Sirivichayakul S; Carvalho AF; Anderson G; Galecki P; Maes M
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):205-216. PubMed ID: 28690204
[TBL] [Abstract][Full Text] [Related]
19. Peripheral kynurenine/tryptophan ratio is not a reliable marker of systemic indoleamine 2,3-dioxygenase: A lesson drawn from patients on hemodialysis.
Chen Y; Xie Z; Xiao C; Zhang M; Li Z; Xie J; Zhang Y; Zhao X; Zeng P; Mo L; Liang X; Shi W
Oncotarget; 2017 Apr; 8(15):25261-25269. PubMed ID: 28445957
[TBL] [Abstract][Full Text] [Related]
20. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]